Home / Pharmaceutical company intelligence
Saffron Pharmaceuticals logo
Pharmaceutical company intelligence

Saffron Pharmaceuticals products and prices in Pakistan

Manufacturer Holds a DRAP Drug Manufacturing Licence (DML) for its products. Source: DRAP.

Follow price changes 🔒 Company report (Pharma Pro)

Pharmaceutical manufacturer · Faisalabad · Pakistan

Faisalabad-based pharmaceutical manufacturer developing and marketing products across anti-infective, endocrine, gastrointestinal and other therapeutic areas.

Saffron Pharmaceuticals products in Pakistan

Saffron Pharmaceuticals has 148 medicine presentations registered in Pakistan under 55 brands, covering 50 generic medicines. Most of its products are in Anti-infectives, Cardiovascular and Vitamins, minerals & nutrition. Its brands with the most registered strengths and packs are Sonnet (Ceftriaxone), Safart (Artemether + Lumefantrine, Artemether), Raxbin (Rivaroxaban) and Safcor (Bisoprolol fumarate). 148 products have an official DRAP price on MedInfoBase. See all 55 brands A to Z

Sourced corporate profile Corporate identity fields are source-tracked; portfolio, price and competitor intelligence remains independently calculated by MedInfoBase.
Official website ↗ Official contact ↗
ShareSend this page
Evidence & freshness

What is sourced, and how recent is it?

Public-source corporate details
Latest regulatory-source observation10 Nov 2026Newest linked source record observed by MedInfoBase
Latest portfolio source check12 Oct 2026Latest source-check date across this published portfolio
Latest effective price date29 Jul 2026Newest effective date among published current price records
Corporate profile evidence5 sourcesCorporate source details checked 16 Aug 2026

Regulatory-source portfolio data and company-supplied/corporate profile fields are tracked separately. Company claim/verification status is separate from source quality. An unclaimed company can still have a fully official-source-observed portfolio.

Regulatory & corporate identity

Company profile

Public-source corporate details
Company type
Pharmaceutical manufacturer
Address
19-Km, Sheikhupura Road, Faisalabad, Pakistan
Phone
+92 41 2423914-5
Official contact
Contact page ↗
Corporate source details checked
16 Aug 2026
Corporate profile completeness
100%
DRAP manufacturing licenceAs published by the DRAP Licensing Division. DRAP issues this list for stakeholder review and states it is not a reference for litigation, claims or citation.
Formulation 000616 Saffron Pharmaceuticals (Pvt) Ltd. · Punjab
Source-linked licence identifiersShown as recorded in linked source rows; not a claim of current validity.
DML 000616 150 linked products · source seen 10 Nov 2026 View source ↗
Location intelligence

Company location

Google Maps
Location recorded

A sourced company location is recorded. Use the map link below for directions.

Open in Google Maps ↗
Intelligence snapshot

Portfolio at a glance

Not sales data · published MedInfoBase database view
Rx166public portfolio records represented
REG122unique registrations represented
IDX148indexed MedInfoBase presentations
SRC6additional source-observed presentations
R+12registry-only registrations
VER76registry-verified exact registrations
PKR148current validated price records
G50generic molecules in indexed catalogue
DF12dosage-form groups
TA12therapeutic areas
How to read these counts

RegistrationA unique regulatory registration number. One registration may have more than one strength/form/pack presentation.

PresentationA distinct medicine presentation, such as a particular strength, dosage form and pack.

IndexedA canonical MedInfoBase presentation that passed MedInfoBase identity and publication controls.

Source observedAn additional presentation observed in an official DRAP source but not counted as an indexed MedInfoBase presentation.

Registry onlyAn exact registry-verified registration not otherwise represented by an indexed or source-observed presentation.

Registry verifiedAn exact registration match found in an official DRAP registry source. This is evidence status, not a commercial ranking.

Data coverage

How complete is this profile?

Current price coverage89%
public portfolio presentations with a validated current price
Official-source coverage100%
products linked back to a source record
Unit-price parse coverage99%
priced packs safely normalized per unit
Comparable-market coverage88%
products with at least one like-for-like comparator
Therapeutic classification100%
products assigned to a broad therapeutic area
Visual intelligence

Downloadable company intelligence charts

Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.

Shareable intelligence

Therapeutic Portfolio Mix

Shows where the company portfolio is concentrated across broad therapeutic areas.

Therapeutic Portfolio MixSaffron PharmaceuticalsShare of current product presentations by broad therapeutic areaMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/saffron-pharmaceuticalsGenerated 10 Nov 2026Anti-infectives82 · 55%Cardiovascular17 · 11%Vitamins, minerals & nutrition12 · 8%Hematology & thrombosis11 · 7%Respiratory & allergy6 · 4%Reproductive & genitourinary5 · 3%CNS & mental health4 · 3%Other therapeutic areas11 · 7%Percentages are based on current product presentations in the MedInfoBase company portfolio.

Portfolio distribution, not sales or market-share data.

Shareable intelligence

Dosage Form Portfolio

Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.

Dosage Form PortfolioSaffron PharmaceuticalsDistribution of current product presentations by normalized dosage formMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/saffron-pharmaceuticalsGenerated 10 Nov 2026148presentationsTablet67 · 45%Injection33 · 22%Suspension13 · 9%Capsule10 · 7%Cream10 · 7%Infusion5 · 3%Other forms10 · 7%Dosage-form wording is normalized for intelligence display; original source wording remains preserved in product records.

Counts are product presentations, not production or sales volumes.

Shareable intelligence

Equivalent Price Position

Shows whether safely comparable products are below, near or above the peer median unit price.

Equivalent Price PositionSaffron PharmaceuticalsCurrent company products compared with like-for-like equivalent medicines using normalized unit pricesMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/saffron-pharmaceuticalsGenerated 10 Nov 2026130comparable productsBelow peer median51 · 39%Near peer median25 · 19%Above peer median54 · 42%Company median price position+1.4%Lowest-price equivalents9Method: same generic + stated strength + dosage form + compatible unit basis; pack prices normalized per unit.

This is price-position intelligence, not sales, demand or market-share data.

Shareable intelligence

Closest Portfolio Competitors

Highlights other manufacturers with the greatest generic overlap with this company portfolio.

Closest Portfolio CompetitorsSaffron PharmaceuticalsCompanies with the largest number of shared generic medicines in the MedInfoBase databaseMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/saffron-pharmaceuticalsGenerated 10 Nov 2026CCL Pharmaceuticals (Pvt.) Limited32 shared64% overlapShaigan Pharmaceuticals (Pvt) Ltd32 shared64% overlapNeutro Pharma (Pvt.) Ltd.,31 shared62% overlapNabiqasim Industries (Pvt) Ltd.,30 shared60% overlapValor Pharmaceuticals30 shared60% overlapBarrett Hodgson Pakistan (Pvt.) Ltd30 shared60% overlapPortfolio overlap measures shared generics only; it is not a measure of market share, affiliation or sales competition.

Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.

Formulation footprint

Dosage forms

Tablet67 products
Injection33 products
Suspension13 products
Capsule10 products
Cream10 products
Infusion5 products
Syrup3 products
Ointment2 products
Pessary2 products
Drops1 products
Lotion1 products
Sachet1 products
How MedInfoBase classifies the portfolio

MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.

Portfolio leaders

Deepest brand families

Ranked by registered presentations · not sales
Price intelligence

Unit-price positioning vs equivalent products

Same generic + strength + form + unit basis
🔒
MedInfoBase Pharma Pro

See where Saffron Pharmaceuticals is priced against the market

130 of its products have like-for-like competitors. Pharma Pro shows how many are priced below, near or above the market median, the company's overall price position, and product-by-product examples.

Below / near / above medianCompany price positionProduct examplesExcel, PDF & PowerPoint
Unlock with Pharma Pro
How MedInfoBase calculates price position

Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.

Competitive landscape

Portfolio overlap

Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.

🔒 3 more overlapping companies, with shared-generic detail, in Pharma Pro. Unlock

Regulatory & price activity

Observed database signals

Indexed registration numbers107Distinct registrations among indexed, published, presentation-validated products only
Verified price observations148
Products with a verified price148
Products with multiple price observations0
Source records with multiple versions148
Latest portfolio source check12 Oct 2026
Latest effective price date29 Jul 2026
Latest source observation10 Nov 2026

These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.

Company medicine portfolio

Medicine portfolio

122 unique registration(s) · 148 indexed presentation(s) · 6 additional source-observed presentation(s) · 12 registry-only registration(s)

This unified portfolio keeps three evidence lanes distinct: indexed MedInfoBase presentations, additional source-observed presentations, and registry-only registrations that are not otherwise represented. A registration number is not the same thing as a presentation, and source-observed rows are not counted as indexed. Source-only rows with a strength/form/pack contradiction remain visible as evidence but the conflicting field is held for normalization.

Reset
BrandGenericStrengthFormPackRegistrationSource-listed priceUnit pricePrice position
Abaxil2.5mg Apixaban 2.5 mg Tablet 30's 104678 PKR 3,522.09 PKR 117.40/tablet 🔒 Pharma Pro
Abaxil5mg Apixaban 5 mg Tablet 30's 104679 PKR 3,744.19 PKR 124.81/tablet 🔒 Pharma Pro
Acefer Iron polymaltose complex 50 mg/5 mL Syrup 60mL 046448 PKR 139.66 PKR 2.33/mL 🔒 Pharma Pro
Acefer Iron polymaltose complex 50 mg/5 mL Syrup 120mL 046448 PKR 239.42 PKR 2.00/mL 🔒 Pharma Pro
Acefer-F Iron polymaltose complex + Folic acid 100 mg elemental iron + 0.35 mg folic acid Tablet 10’s 046447 PKR 137.75 PKR 13.78/tablet 🔒 Pharma Pro
Acefer-F Iron polymaltose complex + Folic acid 100 mg + 0.35 mg Tablet 20 x 10’S 046447 PKR 2,430.74 PKR 12.15/tablet 🔒 Pharma Pro
Amorob Metronidazole 500 mg /100 mL IV infusion 100 mL 052990 PKR 161.10 PKR 1.61/mL No comparator
Amorob Metronidazole 200 mg Tablet 20 x 10’s 081390 PKR 429.11 PKR 2.15/tablet 🔒 Pharma Pro
Amorob Metronidazole 400 mg Tablet 20 x 10’s 081391 PKR 610.83 PKR 3.05/tablet 🔒 Pharma Pro
Amorob Metronidazole 400 mg Tablet 10 x 10’s 081391 PKR 311.65 PKR 3.12/tablet 🔒 Pharma Pro
Amorob Metronidazole 200 mg/5 mL Suspension 60 ml 081392 PKR 66.47 PKR 1.11/mL 🔒 Pharma Pro
Angitryl Nitroglycerin 2.5 mg Tablet 30’s 089408 PKR 311.20 PKR 10.37/tablet No comparator
Angitryl Nitroglycerin 6.4 mg Tablet 30's 107325 PKR 373.67 PKR 12.46/tablet 🔒 Pharma Pro
Angitryl Nitroglycerin 2.6 mg Tablet 30's 111051 PKR 271.63 PKR 9.05/tablet 🔒 Pharma Pro
Azotek Azithromycin 500 mg Tablet 6’s 054170 PKR 575.81 PKR 95.97/tablet 🔒 Pharma Pro
Azotek Azithromycin 500 mg Tablet 3’s 054170 PKR 287.91 PKR 95.97/tablet 🔒 Pharma Pro
Azotek Azithromycin 250 mg Tablet 6’s 064540 PKR 314.05 PKR 52.34/tablet 🔒 Pharma Pro
Azotek Azithromycin 200 mg/5 mL Suspension 15mL 092336 PKR 278.56 PKR 18.57/mL 🔒 Pharma Pro
Caesaf Fluconazole 50 mg Capsule 7's 102416 PKR 722.57 PKR 103.22/capsule 🔒 Pharma Pro
Caesaf Fluconazole 150 mg Capsule 4's 106291 PKR 540.25 PKR 135.06/capsule 🔒 Pharma Pro
Caesaf Fluconazole 150 mg Capsule 1's 106291 PKR 135.06 PKR 135.06/capsule 🔒 Pharma Pro
CeasafSuspensionSource observed Fluconazole — — 35mL 092337Official source ↗ No indexed price — —
Cetrix Cetirizine 10 mg Tablet 20’s 046462 PKR 135.58 PKR 6.78/tablet 🔒 Pharma Pro
Cetrix Cetirizine 10 mg Tablet 10 x 10's 046462 PKR 591.58 PKR 5.92/tablet 🔒 Pharma Pro
Cetrix Cetirizine 10 mg Tablet 10's 046462 PKR 73.95 PKR 7.40/tablet 🔒 Pharma Pro
Cetrix Cetirizine 10 mg Tablet 20 x 10's 046462 PKR 1,183.17 PKR 5.92/tablet 🔒 Pharma Pro
Cetrix Cetirizine 5 mg/5 mL Syrup 60 mL 052955 PKR 66.56 PKR 1.11/mL 🔒 Pharma Pro
Coapt Clotrimazole 500 mg Vaginal tablet 1's 103284 PKR 102.77 PKR 102.77/tablet 🔒 Pharma Pro
Coapt Clotrimazole 2% Vaginal cream 35gm 103285 PKR 112.40 PKR 3.21/g 🔒 Pharma Pro
Coapt Clotrimazole 10% Vaginal cream 5gm 103286 PKR 176.62 PKR 35.32/g No comparator
Coapt Clotrimazole 0.1 g Vaginal tablet 6's 103601 PKR 90.04 PKR 15.01/tablet No comparator
Cytotol Misoprostol 200 mcg Tablet 3 x 10's 064664 PKR 528.92 PKR 17.63/tablet 🔒 Pharma Pro
Cytotol Misoprostol 200 mcg Tablet 10 ‘s 064664 PKR 209.37 PKR 20.94/tablet 🔒 Pharma Pro
Cytotol Misoprostol 200 mcg Tablet 20 x 10's 064664 PKR 3,526.15 PKR 17.63/tablet 🔒 Pharma Pro
Daxolanz 30mg CapsuleRegistry verified Dexlansoprazole Dual Delayed Release Pellets eq. to Dexlansoprazole — — — 102375Official source ↗ No indexed price — —
Daxolanz 60mg CapsuleRegistry verified Dexlansoprazole Dual Delayed Release Pellets eq. to Dexlansoprazole — — — 102376Official source ↗ No indexed price — —
Doplet Cholecalciferol 5 mg Injection 25’s 052954 PKR 5,527.55 PKR 221.10/vial/unit 🔒 Pharma Pro
Doplet-3 Cholecalciferol 5 mg/mL Injection 1’s 052954 PKR 230.32 PKR 230.32/vial/unit 🔒 Pharma Pro
Doplet-3 Cholecalciferol 5 mg/mL Oral drops 10 ml 078963 PKR 833.34 PKR 83.33/mL No comparator
Doplet-3 Cholecalciferol 50000 IU Capsule 100's 115269 PKR 390.28 PKR 3.90/capsule 🔒 Pharma Pro
Edify Midazolam 7.5 mg Tablet 10's 106965 PKR 135.06 PKR 13.51/tablet 🔒 Pharma Pro
Esofil 40mg IV injcetionRegistry verified Esomeprazole as sodium — — — 106487Official source ↗ No indexed price — —
Godicef Cefixime 200 mg Capsule 5's 106485 PKR 292.63 PKR 58.53/capsule 🔒 Pharma Pro
Godicef Cefixime 400 mg Capsule 5's 106486 PKR 487.71 PKR 97.54/capsule 🔒 Pharma Pro
Godicef100mg/5mL Cefixime 100 mg/5 mL Suspension 30mL 106483 PKR 270.12 PKR 9.00/mL 🔒 Pharma Pro
Godicef200mg/5mL Cefixime 200 mg/5 mL Suspension 30mL 106484 PKR 450.21 PKR 15.01/mL 🔒 Pharma Pro
Hypotin Amlodipine 5 mg Tablet 30’s 046463 PKR 318.79 PKR 10.63/tablet 🔒 Pharma Pro
Hypotin Amlodipine 5 mg Tablet 20’s 046463 PKR 216.86 PKR 10.84/tablet 🔒 Pharma Pro
Hypotin Amlodipine 10 mg Tablet 20’s 046464 PKR 295.20 PKR 14.76/tablet 🔒 Pharma Pro
Imunol Tacrolimus 1 mg Tablet 20’s 069173 PKR 2,103.10 PKR 105.16/tablet No comparator
A to Z

All 55 Saffron Pharmaceuticals brands in Pakistan

  • Abaxil2.5mg Apixaban · 2.5 mg tablet
  • Abaxil5mg Apixaban · 5 mg tablet
  • Acefer Iron polymaltose complex · 50 mg/5 mL syrup
  • Acefer-F Iron polymaltose complex + Folic acid · 100 mg + 0.35 mg tablet, 100 mg elemental iron + 0.35 mg folic acid tablet
  • Amorob Metronidazole · 200 mg tablet, 200 mg/5 mL suspension, 400 mg tablet
  • Angitryl Nitroglycerin · 2.5 mg tablet, 2.6 mg tablet, 6.4 mg tablet
  • Azotek Azithromycin · 200 mg/5 mL suspension, 250 mg tablet, 500 mg tablet
  • Caesaf Fluconazole · 150 mg capsule, 50 mg capsule
  • Cetrix Cetirizine · 10 mg tablet, 5 mg/5 mL syrup
  • Coapt Clotrimazole · 0.1 g pessary, 10% cream, 2% cream
  • Cytotol Misoprostol · 200 mcg tablet
  • Doplet Cholecalciferol · 5 mg injection
  • Doplet-3 Cholecalciferol · 5 mg/mL injection, 5 mg/mL drops, 50000 IU capsule
  • Edify Midazolam · 7.5 mg tablet
  • Godicef Cefixime · 200 mg capsule, 400 mg capsule
  • Godicef100mg/5mL Cefixime · 100 mg/5 mL suspension
  • Godicef200mg/5mL Cefixime · 200 mg/5 mL suspension
  • Hypotin Amlodipine · 10 mg tablet, 5 mg tablet
  • Imunol Tacrolimus · 1 mg tablet
  • Karit Clarithromycin · 250 mg tablet, 250 mg/5 mL suspension, 500 mg tablet
  • Locus Levofloxacin · 250 mg tablet, 500 mg tablet, 500 mg infusion
  • Lucid Ciprofloxacin · 125 mg/5 mL suspension, 200 mg/100 mL infusion, 250 mg tablet
  • Microcid Moxifloxacin · 400 mg tablet
  • Mitonil Permethrin · 5% cream, 50 mg/mL lotion
  • Mucolin Acetylcysteine · 200 mg sachet
  • Namet Clomifene citrate · 50 mg tablet
  • Noctis Omeprazole · 20 mg capsule, 40 mg injection, 40 mg capsule
  • Normiron Iron Sucrose Iron sucrose · 100 mg/5 mL injection
  • Omaz Bromazepam · 3 mg tablet
  • Plagril Clopidogrel · 75 mg tablet
  • Plagril Plus Clopidogrel + Aspirin · 75 mg + 75 mg tablet
  • Precort Prednisolone · 5 mg tablet
  • Provate Betamethasone dipropionate, Betamethasone · 0.05% w/w ointment, 0.1% w/w cream, 0.1% w/w ointment
  • Ramos Cefotaxime · 1 G injection, 250 mg injection, 500 mg injection
  • Raxbin Rivaroxaban · 10 mg tablet, 15 mg tablet, 20 mg tablet
  • Rel-Q Silver Silver sulfadiazine · 10 mg cream
  • Resbact Linezolid · 100 mg/5 mL suspension, 200 mg/100 mL infusion, 600 mg/300 mL infusion
  • Safaldi Sofosbuvir · 400 mg tablet
  • Safaldi-L Sofosbuvir · 400 mg tablet
  • Safaldi-V Sofosbuvir · 400 mg tablet
  • Safart Artemether + Lumefantrine, Artemether · 15 mg + 90 mg suspension, 30 mg + 180 mg suspension, 40 mg + 240 mg tablet
  • Safavirin Ribavirin · 200 mg capsule, 600 mg tablet
  • Safcor Bisoprolol fumarate · 10 mg tablet, 2.5 mg tablet, 5 mg tablet
  • Safozac Nifedipine · 10 mg capsule
  • Sar-K Losartan · 100 mg tablet, 50 mg tablet
  • Sar-K Plus Losartan + Hydrochlorothiazide · 50 mg + 12.5 mg tablet
  • Sefkin Amikacin · 100 mg/2 mL injection, 250 mg/2 mL injection, 500 mg/2 mL injection
  • Sinofen Sulfadoxine + Pyrimethamine · 500 mg + 25 mg tablet
  • Sonnet Ceftriaxone · 1 g injection, 2 g injection, 250 mg injection
  • Tenosaf-B Tenofovir disoproxil · 300 mg tablet
  • Terbisil Terbinafine · 1% cream, 1% w/w cream
  • Valpro Divalproex sodium · 250 mg tablet, 500 mg tablet
  • Water for Injection Water for Injection · 5 mL injection
  • WFI Water for Injection · 10 mL injection
  • Zetag Zinc · 20 mg/5 mL suspension
Questions

Saffron Pharmaceuticals: common questions

How many products does Saffron Pharmaceuticals have in Pakistan?

Saffron Pharmaceuticals has 148 registered medicine presentations in Pakistan, sold under 55 brands and covering 50 generic medicines.

What are the main brands of Saffron Pharmaceuticals?

By number of registered strengths and packs, its largest brands are Sonnet (Ceftriaxone), Safart (Artemether + Lumefantrine, Artemether), Raxbin (Rivaroxaban), Safcor (Bisoprolol fumarate) and Amorob (Metronidazole). This is not a sales ranking.

Which therapy areas does Saffron Pharmaceuticals cover?

The most products are in Anti-infectives (82), Cardiovascular (17), Vitamins, minerals & nutrition (12), Hematology & thrombosis (11) and Respiratory & allergy (6).

Where can I see Saffron Pharmaceuticals medicine prices?

Open any brand in the list above for its official DRAP price, pack sizes, price history and other brands of the same medicine.

MedInfoBase company-intelligence methodology

This page is generated from MedInfoBase medicine, generic, company, price and official-source records. Unverified third-party discovery records are retained internally for coverage auditing and are not published as company registrations. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official-source prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.

Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.

Cite this record

Manufacturer record
MedInfoBase. (2026). Saffron Pharmaceuticals — registered product portfolio in Pakistan [Data set]. MedInfoBase. Retrieved November 10, 2026, from https://medinfobase.com/company/saffron-pharmaceuticals/
Download .RIS Download .BIB EndNote, Zotero, Mendeley, RefWorks

Records change over time. Please cite the access date so readers can locate the version you used.

Medicine brands A–Z:ABCDEFGHIJKLMNOPQRSTUVWXYZ0-9